Citi Surprised by Hims Exclusion as Novo Cuts GLP-1 Prices
Citi analyst Daniel Grosslight says competition is increasing in weight-loss drug pricing after Novo Nordisk introduced a $199 monthly offer for Wegovy and Ozempic, leaving out Hims & Hers as a distribution partner.
Already have an account? Sign in.